285P Endogenous retrovirus are shared cancer stem-cell and senescent cell antigens suitable for immunotherapeutic targeting
Cellular senescence is an important driver of cancer development and progression. Endogenous retrovirus (ERVs), remnants of ancient viral infections persists as thousands of partially degraded proviral sequences. ERVs are widely expressed in human and mouse cancer and HERV-K loci of the HML-2 family are known to be reactivated in senescence and cancer. In senescent cells HERV-K reinforces senescence and inflammation, while in cancer cells it supports cell survival, proliferation and invasiveness.
Authors
- KV Grunddal
- AV Bermejo
- PJ Holst
- L. Neukirch
- M. Perez-Penco
- S. Mariya
- L. Duvnjak
- A-M.C. Andersson
- M.D. Müller
- I.S. Pedersen
- S. Schroedel
- H. Darusman
- C. Thirion
Institutions
- University of Copenhagen (DK)
- IPB University (ID)
- Frederiksberg Hospital (DK)
- Herlev Hospital (DK)
- Toptica Photonics (Germany) (DE)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.iotech.2025.101484
- Primary Topic
- Telomeres, Telomerase, and Senescence
- Type
- article
- Field-Weighted Citation Impact
- 0.00